Conflicts of Interest
At Tetron Publications, authors are required to disclose any potential conflicts of interest or financial relationships that may influence their research during manuscript submission. This ensures transparency and maintains the integrity of the publication process. If the manuscript is accepted, the disclosed conflicts of interest will be included in the published article. Our policy aligns with COPE guidelines on conflicts of interest. More details can be found here.
Journal Policy on In-House Submissions
For in-house submissions involving any editorial board member’s work, the respective board member will not participate in the review process. All decisions regarding such manuscripts will be handled by an independent editor, and the manuscripts will be reviewed by two external reviewers.
Permissions to Reproduce Previously Published Material
Authors must obtain permission from the copyright holder to reproduce material, such as illustrations, from other sources. Articles cannot be published without these permissions in place.
Patient Consent Forms
Informed consent must be obtained from potential participants before involvement in research. Authors should ensure that participants are fully informed about the research’s purpose, methods, risks, benefits, and alternatives. A statement confirming that informed consent was obtained must be included in the manuscript’s ‘Methods’ section. Editors may request a copy of the consent form if necessary.
Policy on Artificial Intelligence (AI) Used in Manuscripts
We follow the World Association of Medical Editors (WAME) recommendations regarding the use of artificial intelligence in scientific publications. AI tools like ChatGPT or Large Language Model (LLM) bots cannot be listed as authors of a paper; only humans are accountable for authorship. If AI is used in any part of the research process, such as data collection, writing, editing, table preparation, or image creation, authors must disclose its use in the manuscript. Authors remain fully responsible for the content of their work, including accuracy and ensuring the absence of plagiarism, even when AI tools are involved.
Ethics Committee Approval
All studies involving human participants must have approval from the respective Institutional Review Board (IRB) or Ethics Committee. Guidelines for approval may vary by country, and country-specific ethical standards must be followed. The IRB and protocol numbers should be clearly stated in the manuscript. If the study adheres to the World Medical Association’s (WMA) Declaration of Helsinki ethical principles for medical research involving human subjects, this should be clearly mentioned in the ‘Methods’ section of the manuscript (Click here for more). For studies involving drugs under investigation, such as clinical trials, approval from the FDA or equivalent regulatory authority must be obtained and cited in the manuscript (Click here for more). Studies involving animals must have the approval of the Institutional Animal Care and Use Committee (IACUC), and the protocol number should be included in the manuscript. We adhere to the latest Core Practice Guidelines for Editors and Journal Publishers as outlined by COPE.